Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease
Parker, M.D.
Journal of Laboratory and Clinical Medicine 82(5): 769-775
1973
ISSN/ISBN: 0022-2143 PMID: 4583583 Document Number: 67205
Document emailed within 1 workday
Related Documents
Sönnichsen, N.; Ziegler, H.; Barthelmes, H.; Albrecht-Nebe, H.; Schulze, P.; Brenke, A. 1988: Mixed connective tissue disease (Sharp). Nosologic entity or a subgroup of systemic lupus erythematosus? Dermatologische Monatschrift 174(3): 137-141Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Thomas, J.W.; Vertkin, A.; Nell, L.J. 1987: Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes Journal of Rheumatology 14(4): 732-735
Pallis, M.; Hopkinson, N.; Powell, R. 1991: Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease Journal of Rheumatology 18(10): 1532-1536
Paradowska-Gorycka, A.; Wajda, A.; Stolarek, I.; Felis-Giemza, A.; Walczyk, M.; Nałecz-Janik, J.; Olesińska, M. 2019: Is the T-G-CT-G SNRNP70 haplotype another proof that mixed connective tissue disease is distinct from systemic lupus erythematosus and systemic sclerosis? a novel gene variant in SNRNP70 gene Clinical and Experimental Rheumatology 37 Suppl 119(4): 32-40
Guillet, G.; Gin, H.; Aubertin, J. 1983: Anticytoplasmic antibodies (Ro and La) and connective tissue disease: clinical and biological heterogeneity of systemic lupus La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(8): 513-516
Fishbein, E.; Ramos-Niembro, F.; Alarcon-Segovia, D. 1978: Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases Journal of Rheumatology 5(4): 384-390
Cook, A.D.; Mackay, I.R.; Cicuttini, F.M.; Rowley, M.J. 1997: IgG subclasses of antibodies to type Ii collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases Journal of Rheumatology 24(11): 2090-2096
Christopher-Stine, L.; Wigley, F. 2003: Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease Journal of Rheumatology 30(12): 2725-2727
Dupond, J.L.; Humbert, P.; Mantion, G.; Gillet, M.; Billerey, C.; Mallet, H. 1988: Mixed connective tissue disease with severe esophageal sclerodermic involvement without systemic scleroderma. An unusual form of the overlap syndrome Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(12): 1015-1017
Sinico, R.A.; Radice, A. 2005: The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 22(Suppl 33): S21-S26
Nakano, M.; Ohuchi, Y.; Hasegawa, H.; Kuroda, T.; Ito, S.; Gejyo, F. 2000: Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus Journal of Rheumatology 27(6): 1403-1407
Novak, S. 2009: Clinical significance of antinuclear antibodies and other serological abnormalities in systemic lupus erythematosus (SLE) Reumatizam 56(2): 22-25
Pigrau, A.; Martínez-Vázquez, J.M.; Bacardí, R.; Ocanña, I.; Pahissa, A. 1984: Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus Medicina Clinica 83(19): 787-791
Alpa, M.; Ferrero, B.; Cavallo, R.; Naretto, C.; Gennaro, M.; Bellizia, L.; Sena, L.M.; Roccatello, D. 2002: Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(6): 617-621
Edworthy, S.M. 1995: A database for systemic lupus erythematosus and systemic connective tissue disorders Rheumatic Diseases Clinics of North America 21(2): 501-525
Zdrojewicz, Z.; Budzyń-Kozioł, E.; Puławska, J. 1999: Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment Postepy Higieny i Medycyny Doswiadczalnej 53(5): 751-766
Weber, P.; Ganser, G.; Frosch, M.; Roth, J.; Hülskamp, G.; Zimmer, K.P. 2000: Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease Journal of Rheumatology 27(11): 2692-2695
Gheita, T.A.; Abdel Rehim, D.M.; Kenawy, S.A.; Gheita, H.A. 2015: Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage Acta Reumatologica Portuguesa 40(2): 145-149